Clarivate Plc (CLVT)
Market Cap | 3.35B |
Revenue (ttm) | 2.56B |
Net Income (ttm) | -668.00M |
Shares Out | 691.64M |
EPS (ttm) | -0.96 |
PE Ratio | n/a |
Forward PE | 7.51 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 8,817,088 |
Open | 4.930 |
Previous Close | 4.840 |
Day's Range | 4.680 - 4.980 |
52-Week Range | 4.220 - 9.020 |
Beta | 1.17 |
Analysts | Hold |
Price Target | 7.10 (+46.69%) |
Earnings Date | Feb 19, 2025 |
About CLVT
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academi... [Read more]
Financial Performance
In 2024, Clarivate's revenue was $2.56 billion, a decrease of -2.74% compared to the previous year's $2.63 billion. Losses were -$668.00 million, -32.29% less than in 2023.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price forecast is $7.1, which is an increase of 46.69% from the latest price.
News

Clarivate Plc (CLVT) Q4 2024 Earnings Call Transcript
Clarivate Plc (NYSE:CLVT) Q4 2024 Earnings Conference Call February 19, 2025 9:00 AM ET Company Participants Mark Donohue - VP of IR Matti Shem Tov - CEO Jonathan Collins - CFO Conference Call Partic...

Clarivate Reports Fourth Quarter and Full Year 2024 Results
— Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 m...

Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia
New approach enables broad, simple and affordable access to trusted scholarly content for learning and research LONDON , Feb. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provi...

Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025
Highly recommended in trademark management, searching and watching, renewals and recordals LONDON , Feb. 10, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative...

Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform
Software-as-a-Service, cloud-based library services and discovery platform to be implemented in nine universities and 82 academic and research libraries across Croatia LONDON , Feb. 5, 2025 /PRNewswir...

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON , Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global prov...

Clarivate identifies top 50 universities powering global innovation
Report from the Institute for Scientific Information shows how academic research drives global innovation and benefits society LONDON , Jan. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leadi...

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms
Achieving more unified and secure workflows with cloud-based Alma, Primo and Rapido library software solutions from Clarivate LONDON , Jan. 28, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leadin...

Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025
LONDON , Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter...

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON , Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global pr...

Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Post-marketing Pharmacovigilance and Medical Information Market by Type by Service, by End-User, and By Region" report has been added to ResearchAndMarke...

Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON , Jan. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider...

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON , Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provid...

Clarivate Announces New $500 Million Share Repurchase Authorization
LONDON , Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (...

Clarivate Launches AI-Powered Patent Search Solution in Derwent
Faster and more relevant results to empower critical IP decision-making LONDON , Dec. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, tod...

Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
Revealing highly active specialties in sciences and social sciences LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the...

Daikin Selects IPfolio from Clarivate
Enhancing operational efficiency for leading air conditioner manufacturer LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, a...

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON , Nov. 21, 2024 /PRNewswire/ -- BioWorld ™ published by Clarivate Plc (NYSE:C...

Clarivate Reveals Highly Cited Researchers 2024 List
Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON , Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of tr...

New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON , Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT...

Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc ...

Clarivate Publishes 2023 Sustainability Report
LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its ...

Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover
I downgrade Clarivate PLC from buy to hold due to lack of confidence in near-term organic growth recovery and potential further stock price decline. CLVT's 3Q24 earnings report showed a 3.9% revenue d...

Clarivate Launches New Sustainability Research Solution
ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON , Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leadin...

Clarivate Plc (CLVT) Q3 2024 Earnings Call Transcript
Clarivate Plc (NYSE:CLVT) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Matti Shem Tov - Chief Executive Office...